Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study.

dc.contributor.authorHaro Abad, Josep Maria
dc.contributor.authorHammer-Helmich, Lene
dc.contributor.authorSaragoussi, Delphine
dc.contributor.authorEttrup, Anders
dc.contributor.authorLarsen, Klaus Groes
dc.date.accessioned2020-06-08T22:08:19Z
dc.date.available2020-06-08T22:08:19Z
dc.date.issued2019-06-17
dc.date.updated2020-06-08T22:08:19Z
dc.description.abstractPURPOSE: To investigate the temporal interrelationship between depression severity, cognitive symptoms, and functioning in patients with major depressive disorder (MDD) in the PERFORM study (NCT01427439). PATIENTS AND METHODS: PERFORM was a 2-year, multicenter, prospective, noninterventional cohort study in outpatients with MDD who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Patients were enrolled by a general practitioner or psychiatrist. Structural equation model (SEM) analysis was used to explore temporal associations between patient-reported depression severity (9-item Patient Health Questionnaire score), cognitive symptoms (5-item Perceived Deficits Questionnaire score), and functional impairment (Sheehan Disability Scale total score). Standardized regression coefficients (SRCs) were used to evaluate the relationship between each outcome and scores from the most recent prior visit over the 2 years of follow-up. RESULTS: Between February 25, 2011, and February 19, 2015, 1,159 eligible patients with MDD completed the baseline and ≥1 follow-up visit at 194 sites in five European countries (France, Germany, Spain, Sweden, and the UK). Overall, 1,090 patients had assessments for ≥1 outcome measure at two consecutive visits. Severity of cognitive symptoms at baseline and Months 2 and 18 predicted functional impairment at Months 2, 6, and 24, respectively (SRC: 0.18, 0.15, and 0.22; P<0.001). Depression severity at Months 2, 6, and 12 predicted functional impairment at Months 6, 12, and 18, respectively (SRC: 0.17, 0.25, and 0.22; P<0.001). Severity of cognitive symptoms at baseline and Month 18 predicted depression severity at Months 2 and 24, respectively (SRC: 0.19 and 0.22; P<0.001). Functional impairment did not significantly predict the severity of depression or cognitive symptoms, and depression severity did not significantly predict the severity of cognitive symptoms at any time point. CONCLUSION: Patient-reported severity of cognitive symptoms appears to be an independent and significant determinant of subsequent functional impairment and depression severity in patients with MDD.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec697939
dc.identifier.issn1176-6328
dc.identifier.pmid31616147
dc.identifier.urihttps://hdl.handle.net/2445/164852
dc.language.isoeng
dc.publisherDove Medical Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.2147/ndt.s206825
dc.relation.ispartofNeuropsychiatric Disease and Treatment, 2019, vol. 15, p. 2313-2323
dc.relation.urihttps://doi.org/10.2147/ndt.s206825
dc.rightscc-by-nc (c) Haro Abad, Josep Maria et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationDepressió psíquica
dc.subject.classificationSímptomes
dc.subject.otherMental depression
dc.subject.otherSymptoms
dc.titlePatient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
697939.pdf
Mida:
2.03 MB
Format:
Adobe Portable Document Format